Literature DB >> 32946763

Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.

Michelle R Jones1, Pei-Chen Peng1, Simon G Coetzee1, Jonathan Tyrer2, Alberto Luiz P Reyes1, Rosario I Corona3, Brian Davis1, Stephanie Chen1, Felipe Dezem3, Ji-Heui Seo4, Siddartha Kar5, Eileen Dareng2, Benjamin P Berman6, Matthew L Freedman4, Jasmine T Plummer1, Kate Lawrenson3, Paul Pharoah2, Dennis J Hazelett1, Simon A Gayther7.   

Abstract

Quantifying the functional effects of complex disease risk variants can provide insights into mechanisms underlying disease biology. Genome-wide association studies have identified 39 regions associated with risk of epithelial ovarian cancer (EOC). The vast majority of these variants lie in the non-coding genome, where they likely function through interaction with gene regulatory elements. In this study we first estimated the heritability explained by known common low penetrance risk alleles for EOC. The narrow sense heritability (hg2) of EOC overall and high-grade serous ovarian cancer (HGSOCs) were estimated to be 5%-6%. Partitioned SNP heritability across broad functional categories indicated a significant contribution of regulatory elements to EOC heritability. We collated epigenomic profiling data for 77 cell and tissue types from Roadmap Epigenomics and ENCODE, and from H3K27Ac ChIP-seq data generated in 26 ovarian cancer and precursor-related cell and tissue types. We identified significant enrichment of risk single-nucleotide polymorphisms (SNPs) in active regulatory elements marked by H3K27Ac in HGSOCs. To further investigate how risk SNPs in active regulatory elements influence predisposition to ovarian cancer, we used motifbreakR to predict the disruption of transcription factor binding sites. We identified 469 candidate causal risk variants in H3K27Ac peaks that are predicted to significantly break transcription factor (TF) motifs. The most frequently broken motif was REST (p value = 0.0028), which has been reported as both a tumor suppressor and an oncogene. Overall, these systematic functional annotations with epigenomic data improve interpretation of EOC risk variants and shed light on likely cells of origin.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  cells of origin; epigenomics; epithelial ovarian cancer; functional enrichment; genome-wide association studies; heritability; motif

Mesh:

Substances:

Year:  2020        PMID: 32946763      PMCID: PMC7536645          DOI: 10.1016/j.ajhg.2020.08.021

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  89 in total

Review 1.  DNA binding sites: representation and discovery.

Authors:  G D Stormo
Journal:  Bioinformatics       Date:  2000-01       Impact factor: 6.937

2.  Origin of clear cell carcinoma: nature or nurture?

Authors:  David L Kolin; Daniela M Dinulescu; Christopher P Crum
Journal:  J Pathol       Date:  2018-01-02       Impact factor: 7.996

3.  Characterization of ovarian cancer cell lines as in vivo models for preclinical studies.

Authors:  Lidia Hernandez; Marianne K Kim; L Tiffany Lyle; Kristen P Bunch; Carrie D House; Franklin Ning; Anne M Noonan; Christina M Annunziata
Journal:  Gynecol Oncol       Date:  2016-05-28       Impact factor: 5.482

4.  FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer.

Authors:  Yao Fu; Zhu Liu; Shaoke Lou; Jason Bedford; Xinmeng Jasmine Mu; Kevin Y Yip; Ekta Khurana; Mark Gerstein
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

Review 5.  Mining the Unknown: Assigning Function to Noncoding Single Nucleotide Polymorphisms.

Authors:  Sierra S Nishizaki; Alan P Boyle
Journal:  Trends Genet       Date:  2016-12-06       Impact factor: 11.639

6.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

7.  Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.

Authors:  Sarah A Best; Karla J Hutt; Nai Yang Fu; François Vaillant; Seng H Liew; Lynne Hartley; Clare L Scott; Geoffrey J Lindeman; Jane E Visvader
Journal:  Development       Date:  2014-07-18       Impact factor: 6.868

8.  motifbreakR: an R/Bioconductor package for predicting variant effects at transcription factor binding sites.

Authors:  Simon G Coetzee; Gerhard A Coetzee; Dennis J Hazelett
Journal:  Bioinformatics       Date:  2015-08-12       Impact factor: 6.937

9.  GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.

Authors:  Simon Fishilevich; Ron Nudel; Noa Rappaport; Rotem Hadar; Inbar Plaschkes; Tsippi Iny Stein; Naomi Rosen; Asher Kohn; Michal Twik; Marilyn Safran; Doron Lancet; Dana Cohen
Journal:  Database (Oxford)       Date:  2017-01-01       Impact factor: 3.451

10.  An integrated encyclopedia of DNA elements in the human genome.

Authors: 
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

View more
  5 in total

Review 1.  Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes.

Authors:  Sidrah Shah; Alison Cheung; Mikolaj Kutka; Matin Sheriff; Stergios Boussios
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

2.  chromMAGMA: regulatory element-centric interrogation of risk variants.

Authors:  Robbin Nameki; Anamay Shetty; Eileen Dareng; Jonathan Tyrer; Xianzhi Lin; Paul Pharoah; Rosario I Corona; Siddhartha Kar; Kate Lawrenson
Journal:  Life Sci Alliance       Date:  2022-07-01

3.  A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.

Authors:  Sally Mortlock; Rosario I Corona; Pik Fang Kho; Paul Pharoah; Ji-Heui Seo; Matthew L Freedman; Simon A Gayther; Matthew T Siedhoff; Peter A W Rogers; Ronald Leuchter; Christine S Walsh; Ilana Cass; Beth Y Karlan; B J Rimel; Grant W Montgomery; Kate Lawrenson; Siddhartha P Kar
Journal:  Cell Rep Med       Date:  2022-03-15

4.  Overexpression of NPTX2 Promotes Malignant Phenotype of Epithelial Ovarian Carcinoma via IL6-JAK2/STAT3 Signaling Pathway Under Hypoxia.

Authors:  Xiaotian Han; Yechen Lu; Xiaoqi Li; Lingfang Xia; Hao Wen; Zheng Feng; Xingzhu Ju; Xiaojun Chen; Xiaohua Wu
Journal:  Front Oncol       Date:  2021-03-09       Impact factor: 6.244

5.  A Panel of rSNPs Demonstrating Allelic Asymmetry in Both ChIP-seq and RNA-seq Data and the Search for Their Phenotypic Outcomes through Analysis of DEGs.

Authors:  Elena E Korbolina; Leonid O Bryzgalov; Diana Z Ustrokhanova; Sergey N Postovalov; Dmitry V Poverin; Igor S Damarov; Tatiana I Merkulova
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.